Main Article Content
Introduction: Due to its high incidence and fatality rates, cervical cancer is a significant public health concern in India. In order to increase the chances of people with cervical cancer surviving, early detection and efficient treatment are essential. The current study set out to look into the prevalence of cervical cancer and the characteristics of patients who had the disease at an Indian tertiary care facility.
Methods: The study's methods involved a retrospective examination of cervical cancer patients at an Indian tertiary care facility. During the 2017–2021 study period, 345 instances in total were discovered. The patient's medical records were used to gather the data. The number of cases per 100,000 women was used to determine the incidence of cervical cancer. Age, histological type, and stage at diagnosis were among the patient variables that were examined. Additionally assessed were the patients' results and treatment approaches.
Results: There were 10.8 instances of cervical cancer per 100,000 women annually at the tertiary care facility. Squamous cell carcinomas made up 85.5%. With a standard deviation of 12.5 years, patients were, on average, 47.3 years old. The cervical cancer incidence rate was highest in women aged 45–49, with 16.3 cases per 100,000. Stage III or IV cases made up 68.1% of cases. The most common form of treatment was surgery (74.5%), followed by radiation (38.6%) and chemotherapy (18.6%). Incidences of cervical cancer decreased from 11.2 per 100,000 women in 2017 to 9.5 in 2021.
Conclusion: The current study offers significant new information about the prevalence and features of cervical cancer in an Indian tertiary care facility. It was discovered that the prevalence of cervical cancer at the center was commensurate with the published prevalence rates throughout India. The majority of cases were found to be in an advanced state, underscoring the requirement for better early identification and access to efficient cervical cancer therapy in India. The availability of the HPV vaccine, rising awareness of screening programs, and a downward trend in cervical cancer incidence over time may all be factors.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.